1. Home
  2. RNA vs TCGX Comparison

RNA vs TCGX Comparison

Compare RNA & TCGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

SELL

Current Price

$8.28

Market Cap

141.3M

Sector

Health Care

ML Signal

SELL

TCGX

TCGX Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$10.11

Market Cap

113.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RNA
TCGX
Founded
2025
2026
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.3M
113.4M
IPO Year
2025
2026

Fundamental Metrics

Financial Performance
Metric
RNA
TCGX
Price
$8.28
$10.11
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $23.00
N/A
AVG Volume (30 Days)
205.4K
★ 230.3K
Earning Date
08-13-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$88.07
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.49
$9.90
52 Week High
$73.06
$18.91

Technical Indicators

Market Signals
Indicator
RNA
TCGX
Relative Strength Index (RSI) 39.37 30.04
Support Level $7.56 $9.90
Resistance Level $8.50 $15.00
Average True Range (ATR) 0.35 0.68
MACD 0.17 -0.22
Stochastic Oscillator 54.46 3.39

Price Performance

Historical Comparison
RNA
TCGX

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

About TCGX TCGX Acquisition Corp. Class A Ordinary Shares

TCGX Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.

Share on Social Networks: